Codex DNA, Inc. (DNAY)の価格はいくらですか

Codex DNA, Inc. (DNAY)の価格は$1.30です

Codex DNA, Inc. (DNAY)の時価総額は何ですか

Codex DNA, Inc. (DNAY)の時価総額は$27.96Mです

Codex DNA, Inc. (DNAY) の収益

Operating in the synthetic biology sector, Codex DNA, Inc. develops, manufactures, and sells advanced instruments, reagents, and complementary services. Its primary customer base comprises pharmaceutical firms and academic laboratories worldwide, though it also extends its offerings to government institutions, contract research organizations, and other synthetic biology companies. The company's innovative product portfolio includes the BioXp system, designed to transform digital DNA sequences into usable synthetic DNA, alongside the intuitive BioXp portal, an online platform facilitating DNA sequence design and assembly into chosen vectors. Researchers can also access BioXp kits, which supply essential building blocks and reagents, including the proprietary Gibson Assembly brand, for specific synthetic biology applications. Further support is provided through cloud-based scripts and specialized benchtop reagents for processing products generated by the BioXp system. Moreover, Codex DNA offers Biofoundry Services, allowing clients to commission and receive endpoint-ready BioXp products like genes, clones, cell-free amplified DNA, and variant libraries, in addition to providing short oligo ligation assembly enzymatic DNA synthesis. Established in 2011 and headquartered in San Diego, California, the company rebranded as Codex DNA, Inc. in March 2020, having previously been known as SGI-DNA, Inc.

年	収益	変化
提供された日付のデータは十分ではありません。

年

収益

変化

提供された日付のデータは十分ではありません。

企業	収益	収益の差	国
Abbott Laboratories ABT.US	$46.59B	-	US
Stryker Corporation SYK.US	$25.84B	-	US
Medtronic plc MDT.US	$35.48B	-	IE
Boston Scientific Corporation BSX.US	$21.00B	-	US
Edwards Lifesciences Corporation EW.US	$6.51B	-	US

企業

収益

収益の差

国